Specific treatment of ATTR‑CM in Germany – expert consensus of the German Society of Amyloid Diseases (DGAK) and German Cardiac Society (DGK) AndreaSaidi2026-11-12T13:29:30+01:00 Weiterlesen
Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany – expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN) AndreaSaidi2026-11-12T13:35:53+01:00 Weiterlesen
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases AndreaSaidi2026-11-12T13:35:17+01:00 Weiterlesen
